Literature DB >> 2866946

The urticarias. Current concepts in pathogenesis and treatment.

K P Mathews.   

Abstract

Urticaria is a very common disease which is often associated with angioedema. Release of histamine and perhaps other mediators from the cutaneous mast cells is believed to be the likeliest cause for the development of these wheals in most instances, but there may be both non-immunological as well as immunological inputs into this final common pathway. The former include trauma, cholinergic mechanisms and non-immunological histamine release by drugs. Immune mechanisms most commonly are of the IgE-mediated type, but occasionally the activation of complement or other mediators of hypersensitivity may be involved. Drug and food allergy are among the most common causes of acute urticaria, but there are numerous other possibilities which mandate a thorough general medical history and physical examination (including ruling out infection, connective tissue disease and neoplasms). In cases of chronic urticaria, when the lesions have persisted for longer than about 2 months, no cause for the disease is discernable in most instances. However, in these cases, as well as in acute urticaria, symptomatic treatment generally can provide substantial symptom relief, with emphasis on the astute use of various types of antihistamines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866946     DOI: 10.2165/00003495-198530060-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  12 in total

1.  Histamine release by compounds of simple chemical structure.

Authors:  W D PATON
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

Review 2.  Management of urticaria and angioedema.

Authors:  K P Mathews
Journal:  J Allergy Clin Immunol       Date:  1980-11       Impact factor: 10.793

Review 3.  Urticaria and angioedema.

Authors:  K P Mathews
Journal:  J Allergy Clin Immunol       Date:  1983-07       Impact factor: 10.793

4.  Laboratory tests in chronic urticaria.

Authors:  K W Jacobson; L B Branch; H S Nelson
Journal:  JAMA       Date:  1980-04-25       Impact factor: 56.272

5.  Skin histamine in chronic urticaria.

Authors:  P Phanuphak; A L Schocket; C M Arroyave; P F Kohler
Journal:  J Allergy Clin Immunol       Date:  1980-05       Impact factor: 10.793

6.  Delayed pressure urticaria.

Authors:  G L Sussman; R P Harvey; A L Schocket
Journal:  J Allergy Clin Immunol       Date:  1982-11       Impact factor: 10.793

7.  Combined H1 and H2 antihistamine therapy in chronic urticaria.

Authors:  E W Monroe; S H Cohen; J Kalbfleisch; C I Schulz
Journal:  Arch Dermatol       Date:  1981-07

8.  Histologic studies of chronic idiopathic urticaria.

Authors:  S F Natbony; M E Phillips; J M Elias; H P Godfrey; A P Kaplan
Journal:  J Allergy Clin Immunol       Date:  1983-02       Impact factor: 10.793

9.  The functional and physicochemical characterization of three eosinophilotactic activities released into the circulation by cold challenge of patients with cold urticaria.

Authors:  S I Wasserman; K F Austen; N A Soter
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

10.  Familial carboxypeptidase N deficiency.

Authors:  K P Mathews; P M Pan; N J Gardner; T E Hugli
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

View more
  2 in total

Review 1.  Histamine2 (H2)-receptor antagonists in the treatment of urticaria.

Authors:  T C Theoharides
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

Review 2.  Advances in anti-IgE therapy.

Authors:  Arzu Didem Yalcin
Journal:  Biomed Res Int       Date:  2015-05-05       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.